JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD.

Altre lingue Joincare Pharmaceutical Group Industry Co.,Ltd.

Azioni

600380

CNE000001816

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 28/06/2024			Variaz. 5gg	Var. 1 gen.
11,17 ^CNY	-1,50%		-6,37%	-10,14%

13/06	La Cina approva il farmaco antiasma di Joincare	MT
28/05	La Cina approva il farmaco per l'asma dell'unità Joincare	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

China Approves Joincare's Anti-Asthma Drug	13/06
China Approves Joincare Unit's Asthma Drug	28/05
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint	18/04
Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study	18/04
Joincare Pharmaceutical Group's 2023 Profit Falls 4%; Shares Slide 4%	03/04
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04
Livzon Pharma to Trial JP-1366 Tablets as Reflux Esophagitis Drug	23/02
Livzon Pharmaceutical Appoints Former Joincare Exec as Vice President	30/01
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment	29/01
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with Joincare Pharmaceutical Group Industry Co., Ltd	26/01
Joincare Pharmaceutical, Guangzhou Fermion Technology Get Nod to Trial Analgesic Drug	12/01
Livzon Pharmaceutical to Continue Getting Services from Joincare Pharmaceutical	02/01
Joincare Pharma’s 210 Drugs Included in China's Medical Insurance Catalog	14/12
Joincare Gets Nod to Trial Pain Relief Drug	05/12
Joincare Pharma Shortlisted For China’s Drug Procurement Program	07/11
Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.	31/10/23
Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback announced on December 15, 2022 has closed with 49,706,643 shares, representing 2.61% for CNY 599.91 million.	27/10/23
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Joincare Pharma Unit Gets Go Signal from China for Phase 3 Trial of Endometriosis Drug	17/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Joincare Pharmaceutical Group Industry Co.,Ltd.

Azioni

600380

CNE000001816

Altre lingue

Filtri